Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.
about
Improving Atrial Fibrillation Therapy: Is There a Gene for That?Gene Therapy for Atrial Fibrillation in Heart Failure.Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetesBiological therapies targeting arrhythmias: are cells and genes the answer?MicroRNA-30c suppresses the pro-fibrogenic effects of cardiac fibroblasts induced by TGF-β1 and prevents atrial fibrosis by targeting TGFβRII.The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation.
P2860
Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Constitutive Expression of a D ...... Atrial Fibrillation Substrate.
@en
Constitutive Expression of a D ...... Atrial Fibrillation Substrate.
@nl
type
label
Constitutive Expression of a D ...... Atrial Fibrillation Substrate.
@en
Constitutive Expression of a D ...... Atrial Fibrillation Substrate.
@nl
prefLabel
Constitutive Expression of a D ...... Atrial Fibrillation Substrate.
@en
Constitutive Expression of a D ...... Atrial Fibrillation Substrate.
@nl
P2093
P2860
P1433
P1476
Constitutive Expression of a D ...... Atrial Fibrillation Substrate
@en
P2093
Aaron Kunamalla
Bradley P Knight
David Gordon
Gary Aistrup
Jeffrey J Goldberger
Jon Lomasney
Kate A McGee
Qiang Zhang
Rishi Arora
P2860
P356
10.1161/CIRCRESAHA.115.307878
P50
P577
2016-05-23T00:00:00Z